Sulphasalazine and regression of rheumatoid nodules.
The regression of small rheumatoid nodules was noted in four patients after starting sulphasalazine therapy. This coincided with an improvement in synovitis and also falls in erythrocyte sedimentation rate (ESR) and C reactive protein (CRP). The relation between the nodule regression and the sulphasalazine therapy is discussed.
D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012218:Rheumatoid Nodule / Q000188:drug therapy*; D012460:Sulfasalazine / Q000627:therapeutic use*
D012460:Sulfasalazine